![](https://photos.idnfinancials.com/d/1600x900/medical-563427_1920.jpg&nc)
Kalbe Farma to place USD 10 million investment in Progen
17 Jan 2023 06:37
PT Kalbe Farma Tbk (KLBF), a pharmaceutical company, has made an investment worth USD 10 million in Progen Co. Ltd. to enhance the collaboration of research and development (R&D) in biological drugs.